Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Intra-Cellular Therapies Settles CAPLYTA® (lumateperone) Patent Litigation with Sandoz
-
Dyne Therapeutics Reports New Clinical Data Showing Compelling Impact on Multiple Measures of Myotonic Dystrophy Type 1 (DM1); Dyne Plans to Initiate Registrational Expansion Cohort to Support Potenti
-
Auction result of Treasury Bonds - RIKB 27 0415 - RIKB 35 0917
-
Marqeta to Announce Fourth Quarter and Full Year 2024 Results on February 26, 2025
-
Global Blue Releases the Monthly Tax Free Shopping Business Update for December 2024
-
TOYOTA GAZOO Racing Exhibiting at Tokyo Auto Salon 2025
-
Inspira™ Preparing Production in Response to Spread of Respiratory Virus in China
-
Tikehau Capital: Disclosure of Shares Repurchases From 03 January 2025 to 09 January 2025
-
Net Asset Value(s)
-
C4 Launches KOL Incubation School to Empower the Next Generation of Crypto Content Creators
-
PacBio and Intus Bio Collaborate for Launch of GutID, First At-Home Microbiome Test Powered by HiFi Sequencing
-
Mersana Therapeutics Announces Additional FDA Fast Track Designation Granted to Emiltatug Ledadotin (XMT-1660)
-
Diamyd Medical confirms key advances toward Accelerated Approval for Diamyd® following FDA Type C Meeting
-
16 Press Releases You Need to See This Week
-
Fineqia Ltd Reports 38.4% Increase in Digital Asset Blockchain Infrastructure AMC's Year-End Net Asset Value
-
Happy Belly's HEAL Wellness QSR Announces the Grand Opening of its Newest Location at the University of Alberta
-
FunEasyLearn Announces Gift Cards Just in Time for the Holiday Season
-
Maple Leaf Foods Lays Groundwork for Transformational Year Ahead
-
Camino Announces Restructured Private Placement of up to C$2.0 Million and Proposed Consolidation
-
EXEL Industries: Total number of voting rights and shares at 11.30.2024
-
Mersana Therapeutics Announces Positive Initial Clinical Data from Phase 1 Clinical Trial of Emiltatug Ledadotin (XMT-1660); Initiation of Expansion in Triple Negative Breast Cancer
-
ChipMOS EXPECTS 6.3% FULL YEAR 2024 REVENUE GROWTH, WITH A 5.4% YoY DECEMBER 2024 REVENUE DECLINE AND A 5.7% YoY 4Q24 REVENUE DECLINE
-
Ouro Medicines Launches to Define the Future of Treatment for People with Immune-Mediated Diseases
-
Aura Announces Q4 2024 Production Results, Achieving 2024 Guidance
-
Maple Leaf Foods Increases Quarterly Dividend by 9% and announces First Quarter Distribution
-
Insulet to Announce Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025
-
City Therapeutics Announces Strategic Collaboration with Bausch + Lomb to Develop a Novel RNAi-Based Treatment for Geographic Atrophy
-
Modivcare Raises $105 Million in Incremental Financing Backed by Stakeholders Across the Capital Structure and Takes Strategic Steps to Position Business for the Future
-
Li-Cycle Provides Preliminary Commercial and Operational Highlights for 2024
-
Armada Hoffler Announces Morningstar Upgrades Outlook to Stable and Confirms BBB Credit Rating
-
Everything Blockchain Inc. Resolves Toxic Convertible Notes, Strengthening Financial Position
-
Biodesix Announces Preliminary Fourth Quarter and Full-Year 2024 Results (Unaudited)
-
Liquid Youth Nutrition and Wildside Online Partner to Promote the 19th Annual Liquid Youth 13.1 Fort Lauderdale Running Festival on November 9, 2025. Register Now!
-
Toobit Expands Language Support: Dutch, Indonesian, and Polish Now Available
-
Form 8.5 (EPT/RI)-De La Rue plc
-
EXEL Industries: Total number of voting rights and shares at 10.31.2024
-
Form 8.3 - [LEARNING TECHNOLOGIES GROUP PLC - 09 01 2025] - (CGWL)
-
Becrypt Launches VDI Guard: Securing Critical Infrastructure by Mitigating Remote Access Protocol Vulnerabilities.
-
GlobalLogic Announces Leadership Change: Srini Shankar Appointed as President and Chief Executive Officer
-
Sensory Pioneer AAC Technologies Unveils Comprehensive Advanced Solutions at CES 2025, Raising the Bar for the Industry
-
SuperWalk Makes Strategic Move with HashKey Exchange Listing to Drive Global Expansion
-
Dimensional Fund Advisors Ltd. : Form 8.3 - HARGREAVES LANSDOWN PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - BRITVIC PLC - Ordinary Shares
-
China Telecom's TeleNavi: Voice-Only Intelligent Location Technology Helps to Break Through 'The Digital Travel Dilemma' For the Elderly
-
Market Eyes "Crypto President" Inauguration as BTC Tumbles at $100K: Bybit and Block Scholes Analysis
-
HSBC Bank Plc - Form 8.5 (EPT/RI) - Team Internet Group plc
-
HSBC Bank Plc - Form 8.5 (EPT/RI) - Learning Technologies Group plc
-
ZEGAZ Instruments Unveils PhaseAlarm: A Game-Changer for Gas Analyzer Protection
-
ZWSOFT 2024 Year in Review: Empowering Sustainable Innovation
-
IBUSINESSPLAN Helps Simplifying Business Plans for EB2-NIW, E2, and L1 Visa Applicants
